# Developmental Funds

> **NIH NIH P30** · SALK INSTITUTE FOR BIOLOGICAL STUDIES · 2022 · $720,836

## Abstract

Developmental Funds - Project Summary/Abstract 
Developmental Funds provide the Cancer Center Director the opportunity to identify and recruit new young 
investigators into the Cancer Center, helping to expand the research initiatives of the Center. Pilot Grant 
awards provide a mechanism for the Director to promote and steer collaborative projects into new and exciting 
translational and technological areas. The use of Developmental Funds is determined by the Director with input 
from the Senior Leadership. The use of these funds has proven to be very successful. The investigators who 
have received funds over the course of this CCSG now in year 45 have been highly successful and remain in 
the Salk Cancer Center, as evidenced by the fact that all but one member of the current leadership were at one 
time recipients of these funds. In addtion to the New Investigators Program and Pilot Grant Program 
Developmental Funds have supported the building of several new Shared Resources over the past 15 years. 
Developmental Funds have been foundational to the success of Salk Cancer Center.

## Key facts

- **NIH application ID:** 10328948
- **Project number:** 5P30CA014195-49
- **Recipient organization:** SALK INSTITUTE FOR BIOLOGICAL STUDIES
- **Principal Investigator:** Reuben Shaw
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $720,836
- **Award type:** 5
- **Project period:** 1996-12-31 → 2024-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10328948

## Citation

> US National Institutes of Health, RePORTER application 10328948, Developmental Funds (5P30CA014195-49). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10328948. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*